Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release

European Journal of Endocrinology

Volumn 137, Issue 4, 1997, Pages 377-386

  Friend, Keith ^c,d   Iranmanesh, Ali ^a   Login, Ivan S ^b   Veldhuis, Johannes D ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PYRIDOSTIGMINE; SOMATOSTATIN;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CHOLINERGIC STIMULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEEDBACK SYSTEM; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NORMAL HUMAN; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ENTROPY; HALF-LIFE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PARASYMPATHOMIMETICS; PULSATILE FLOW; PYRIDOSTIGMINE BROMIDE; REGRESSION ANALYSIS;

EID: 0030876260     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1370377     Document Type: Article

References (50)

1. Veldhuis JD. Physiological regulation of GH secretion throughout the human lifetime. Current Medical Literature - Growth Hormone and Growth Factors 1995 10 59-68.
2. Ghigo E, Arvat E, Bellone J, Ramunni J & Camanni F. Neurotransmitter control of growth hormone secretion in humans. Journal of Pediatric Endocrinology 1993 6 263-266.
3. Veldhuis JD & Iranmanesh A. Age-dependent changes in growth hormone secretion in adults. In Recent Advances in the Neuroendocrinology of Aging, pp 71-93. Eds W Scherbaum & WG Rossmanith. Berlin: Walter De Gruyter & Co., 1994.
4. Ghigo E, Imperiale E, Mazza E, Goffi S, Procopio M, Muller EE & Camanni F. Cholinergic enhancement of pyridostigmine potentiates spontaneous diurnal but not nocturnal growth hormone secretion in short children. Neuroendocrinology 1989 49 134-137.
5. Loche S, Pintor C, Cappa, Ghigo E, Puggioni R, Locatelli V & Muller EE. Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children. Acta Endocrinologica 1989 120 624-628.
6. Ghigo E, Mazza E, Corrias A, Imperiale E, Goffi S, Arvat E, Bellone J, De Sanctis C, Muller EE & Camanni F. Effect of cholinergic enhancement by pyridostigmine on growth hormone secretion in obese adults and children. Metabolism: Clinical and Experimental 1989 38 631-633.
7. Panzeri G, Torsello A, Cella SG, Muller EE & Locatelli V. Age-related modulatory activity by a cholinergic agonist on the growth hormone response to GH-releasing hormone in the rat. Proceedings of the Society for Experimental Biology and Medicine 1990 193 214-219.
8. Magnan E, Cataldi M, Guillaume V, Mazzocchi L, Dutour A, Conte-Devolx B, Giraud P & Oliver C. Neostigmine stimulates growth hormone-releasing hormone release into hypophysial portal blood of conscious sheep. Endocrinology 1993 132 1247-1251.
9. Jaffe CA, DeMott FR & Barkan AL. Involvement of endogenous growth hormone (GH)-releasing hormone in the GH responses to physiological and pharmacological stimuli. Journal of Clinical Investigation 1996 97 934-940.
10. Locatelli V, Torsello A, Redalli M, Ghigo E, Massara F & Muller EE. Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone releasing hormone in the rat: evidence for mediation by somatostatin. Journal of Endocrinology 1984 111 271-278.
11. Torsello A, Panzeri G, Cermenati P, Caroleo MC, Ghigo E, Camanni F, Muller EE & Locatelli V. Involvement of the somatostatin and cholinergic systems in the mechanisms of growth hormone autoregulation in the rat. Journal of Endocrinology 1988 117 273-281.
12. Massara F, Ghigo E, Molinatti GM, Mazza E, Locatelli V, Muller EE & Camanni F. Potentiation of cholinergic tone by pyridostigmine bromide reinstates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone releasing factor in man. Acta Endocrinologica 1986 113 12-16.
13. Ross RSM, Tsagarakis S & Grossman A. GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH. Clinical Endocrinology 1987 27 722-733.
14. Veldhuis JD, Carlson ML & Johnson ML. The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous-multiple-parameter deconvolution of plasma hormone concentrations. Proceedings of the National Academy of Sciences of the USA 1987 84 7686-7690.
15. Johnson ML & Veldhuis JD. Evolution of deconvolution analysis as a hormone pulse detection method. Methods in Neurosciences 1995 28 1-24.
16. Veldhuis JD & Johnson ML. Specific methodological approaches to selected contemporary issues in deconvolution analysis of pulsatile neuroendocrine data. Methods in Neurosciences 1995 28 25-92.
17. Pincus SM. Approximate entropy as a measure of system complexity. Proceedings of the National Academy of Sciences of the USA 1991 88 2297-2301.
18. Pincus SM & Keefe DL. Quantification of hormone pulsatility via an approximate entropy algorithm. American Journal of Physiology 1992 262 E741-E754.
19. Hartman ML, Pincus SM, Johnson ML, Matthews DH, Faunt LM, Vance ML, Thorner MO & Veldhuis JD. Enhanced basal and disorderly growth hormone (GH) secretion distinguish acromegalic from normal pulsatile GH release. Journal of Clinical Investigation 1994 94 1277-1288.
20. Iranmanesh A, Grisso B & Veldhuis JD. Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay. Journal of Clinical Endocrinology and Metabolism 1994 78 526-535.
21. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD & Thorner MO. Enhanced sensitivity growth hormone chemiluminescence assay reveals lower post-glucose nadir GH concentrations in men than women. Journal of Clinical Endocrinology and Metabolism 1994 78 1312-1319.
22. Straume M, Veldhuis JD & Johnson ML. Model-independent quantification of measurement error: empirical estimation of discrete variance function profiles based on standard curves. Methods in Enzymology 1994 240 121-150.
23. Friend KE, Iranmanesh A & Veldhuis JD. The orderliness of the GH release process and the mean mass of GH secreted per burst are highly conserved in individual men on successive days. Journal of Clinical Endocrinology and Metabolism 1996 81 3746-3753.
24. Straume M, Veldhuis JD & Johnson ML. Realistic emulation of highly irregular temporal patterns of hormone release: a computer-based pulse simulator. Methods in Neurosciences 1995 28 220-243.
25. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan Y, Johnson ML, Pincus SM, Straume M & Iranmanesh A. Differential impact of age, sex-steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. Journal of Clinical Endocrinology and Metabolism 1995 80 3209-3222.
26. Pincus SM. Approximate entropy (ApEn) as a complexity measure. Chaos 1995 5 110-117.
27. Pincus SM. Greater signal regularity may indicate increased system isolation. Mathematical Biosciences 1994 122 161-181.
28. Pincus SM. Quantifying complexity and regularity of neurobiological systems. Methods in Neurosciences 1995 28 336-363.
29. Pincus SM & Singer BH. Randomness and degrees of irregularity. Proceedings of the National Academy of Sciences of the USA 1996 93 2083-2088.
30. Pincus SM & Huang WM. Approximate entropy: statistical properties and applications. Communications in Statistics: Theory and Methods 1992 21 3061-3077.
31. Cordido F, Dieguez C & Casanueva FF. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects. Journal of Clinical Endocrinology and Metabolism 1990 70 1361-1370.
32. Casanueva FF, Betti R, Cella SG, Muller EE & Mantegazza P. Effects of agonists and antagonists of cholinergic neurotransmission on growth hormone release in the dog. Acta Endocrinologica 1983 103 15-19.
33. Ghigo E, Bellone J, Mazza E, Imperiale E, Procopio M, Valente F, Lala R, De Sanctis C & Camanni F. Arginine potentiates the GHRH-but not the pyridostigmine-induced GH secretion in normal short children. Further evidence for a somatostatine suppressing effect of arginine. Clinical Endocrinology 1990 32 763-766.
34. Ghigo E, Arvat E, Goffi S, Bellone J, Valente F, Procopio M, Ghigo MC & Camanni F. Repetitive GHRH and arginine administration to explore the maximal secretory capacity of somatotrope cells during lifespan. Clinical and Experimental Endocrinology 1991 10 191-198.
35. Arvat E, Cappa M, Casanueva FF, Diequez C, Ghigo E, Nicolosi M, Valcavi R & Zini M. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women. Journal of Clinical Endocrinology and Metabolism 1993 76 374-377.
36. Iranmanesh A & Veldhuis JD. Clinical pathophysiology of the somatotropic (GH) axis in adults. Endocrinology and Metabolism Clinics of North America 1992 21 783-816.
37. Mazza E, Ghigo E, Boffano G, Valetto M, Maccario M, Arvat E et al. Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans. European Journal of Pharmacology 1994 254 17-20.
38. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik R et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. Journal of Clinical Endocrinology and Metabolism 1987 64 51-58.
39. Cella SG, Arce VM, Pieretti F, Locatelli V, Settembrini BP & Muller EE. Combined administration of growth hormone-releasing hormone and clonidine restores defective growth hormone secretion in old dogs. Neuroendocrinology 1993 57 432-438.
40. Muller EE, Cocchi D, Ghigo E, Arvat E, Locatelli V & Camanni F. Growth hormone response to GHRH during lifespan. Journal of Pediatric Endocrinology 1993 6 5-13.
41. Weltman A, Weltman JY, Hartman ML, Abbott RA, Rogol AD, Evans WS & Veldhuis JD. Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: effects of gender. Journal of Clinical Endocrinology and Metabolism 1994 78 543-548.
42. Martha PM Jr, Gorman KM, Blizzard RM, Rogol AD & Veldhuis JD. Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status, and body mass. Journal of Clinical Endocrinology and Metabolism 1992 74 336-344.
43. Bellone J, Ghigo E, Procopio M, Arvat E, Valente F, Boffano GM, Maccario M, Dentelli P & Camanni F. Comparison of the potentiating effect of pyridostigmine, arginine and propranolol on the GHRH-induced GH release in short children. Panminerva Medico 1993 35 1-4.
44. Stone JG, Matteo RS, Ornstein E, Schwartz AE, Ostapkovich N, Jamdar SC & Diaz J. Aging alters the pharmacokinetics of pyridostigmine. Anesthesia and Analgesia 1995 81 773-776.
45. Cordido F, Penalva A, Dieguez C & Casanueva FF. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. Journal of Clinical Endocrinology and Metabolism 1993 76 819-823.
46. Pincus SM, Gevers E, Robinson ICA, Roelfsema F, Hartman ML & Veldhuis JD. Females secrete growth hormone with more process irregularity than males in both human and rat. American Journal of Physiology (Regulatory, Integrative, and Comparative Physiology) 1996 270 E107-E115.
47. Vahl N, Jorgensen JOL, Skjaerback C, Veldhuis JD, Orskov H & Christiansen J. Abdominal adiposity rather than age and sex predicts the mass and patterned regularity of growth hormone secretion in healthy adults. American Journal of Physiology 1997 (In Press).
48. Van den Berg G, Pincus S, Veldhuis JD, Frolich M & Roelfsema F. Greater disorderliness of adrenocorticotropin and cortisol release accompanies pituitary-dependent Cushing's Disease. European Journal of Endocrinology 1997 (In Press).
49. Giustina A, Scalvini T, Tassi C, Desenzani P, Poiesi C, Wehenberg W, Rogol A & Veldhuis JD. Maturation of the regulation of pulsatile and stimulated growth hormone secretion in men: a longitudinal study in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone levels. Journal of Clinical Endocrinology and Metabolism 1997 82 1210-1219.
50. Pincus SM, Mulligan T, Iranmanesh A, Gheorghiu S, Godschalk M & Veldhuis JD. Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males: dual novel facets. Proceedings of the National Academy of Sciences of the USA 1996 93 14100-14105.